sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor

Yangbin Pan1, Jianxin Wan2, Yipeng Liu1

  • 1Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Scientific Reports
|October 23, 2014
PubMed

Insights

Secretory phospholipase A2 (sPLA2 IB) binding to the M-type phospholipase A2 receptor (PLA2R) on podocytes induces kidney cell apoptosis. This interaction activates signaling pathways and increases arachidonic acid, contributing to glomerular disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • The M-type phospholipase A2 receptor (PLA2R) is present in human glomerular podocytes.
  • Group IB secretory phospholipase A2 (sPLA2 IB) is a PLA2R ligand with elevated levels in chronic renal failure.
  • The specific roles of PLA2R and sPLA2 IB in glomerular disease pathogenesis remain unclear.

Purpose of the Study:

  • To investigate the role of the PLA2R and sPLA2 IB in the pathogenesis of glomerular diseases.
  • To elucidate the mechanism by which sPLA2 IB interacts with PLA2R and affects podocyte apoptosis.

Main Methods:

  • Analysis of PLA2R and serum sPLA2 IB levels in relation to podocyte apoptosis in kidney biopsies.
  • In vitro studies using human podocyte cell cultures to examine sPLA2 IB-PLA2R interactions.
  • Assessment of podocyte apoptosis, PLA2R expression, ERK1/2 and cPLA2α phosphorylation, and arachidonic acid (AA) content following sPLA2 IB treatment.
  • Utilizing PLA2R-silenced podocytes to evaluate the receptor's role in apoptosis.

Main Results:

  • Higher PLA2R and serum sPLA2 IB levels correlated with increased podocyte apoptosis in patients.
  • In vitro, sPLA2 IB binding to PLA2R on human podocytes induced apoptosis in a time- and concentration-dependent manner.
  • sPLA2 IB upregulated PLA2R, increased ERK1/2 and cPLA2α phosphorylation, and enhanced podocyte apoptosis.
  • PLA2R silencing attenuated sPLA2 IB-induced apoptosis, and sPLA2 IB increased podocyte AA content.

Conclusions:

  • sPLA2 IB induces human podocyte apoptosis through binding to PLA2R.
  • The sPLA2 IB-PLA2R interaction activates ERK1/2 and cPLA2α signaling pathways.
  • Increased podocyte arachidonic acid content is a consequence of the sPLA2 IB-PLA2R interaction, contributing to podocyte apoptosis and potentially glomerular diseases.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
9
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...
12
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.0K